Mood disorders, including anxiety and depression, are thought to be characterized by disrupted neuronal synapses and altered brain plasticity. The etiology is complex, involving numerous regions of the brain, comprising a multitude of neurotransmitter and neuromodulator systems. Recently, new studies on the teneurins, an evolutionary ancient family of type II transmembrane proteins have been shown to interact with latrophilins (LPHN), a similarly phylogenetically old family of adhesion G protein-coupled receptors (GPCR) forming a transsynaptic adhesion and ligand-receptor pair. Each of the four teneurin proteins contains bioactive sequences termed the teneurin C-terminal associated peptides (TCAP-1-4), which possess a number of neuromodulatory effects. The primary structures of the TCAP are most closely similar to the corticotropin-releasing factor (CRF) family of peptides. CRF has been implicated in a number of diverse mood disorders. Via an association with dystroglycans, synthetic TCAP-1 administration to both embryonic and primary hippocampal cultures induces long-term changes in neuronal structure, specifically increased neurite outgrowth, dendritic branching, and axon growth. Rodent models treated with TCAP-1 show reduced anxiety responses in the elevated plus-maze, openfield test, and acoustic startle test and inhibited CRF-mediated cocaine-seeking behaviour. Thus the teneurin/ TCAP-latrophilin interaction may play a major role in the origin, development and treatment of mood disorders.
Introduction

Etiology of mood disorders
There is a high lifetime prevalence of mood disorders among adults (approximately 21%), and this is a concerning issue, as mood disorders are associated with an increased mortality risk [1] . The clinical manifestations of mood disorders involve a change in the emotional state, and can involve anxiety, depression, or mania [2] . These changes negatively affect the cognitive functioning of the individual, are economically damaging and may contribute to a poor quality of life [3] . Thus, it is important for current research to delineate the anatomical and pharmacological pathways associated with affective disorders.
Understanding the neurobiology behind mood disorders has proven to be a considerable challenge, as there are many overlapping neural circuits and predisposing factors. For example, abnormal structural changes in both the hippocampus and amygdala are implicated in both depression and anxiety. Research shows patients with anxiety have reduced neuronal connections between emotion processing (i.e. amygdala) and emotion modulation regions (i.e. medial prefrontal cortex) [3] . In depressed patients, MacQueen et al. [4] found decreased hippocampal volume, and impaired explicit memory and contextual learning. It was suggested that reduced hippocampal volume might be partly due to the retraction of dendrites. [3] . However, patients prescribed with serotonergic anti-depressants experience unwanted side effects and do not have complete symptom relief, indicating a need for improved treatments. Furthermore, individuals may be predisposed to mood disorders if they have an increased vulnerability to stress and/or have been consistently exposed to a stressful environment. Glucocorticoid hormones, as a result of corticotropin-releasing factor (CRF) secretion, become elevated during stress; and prolonged CRF signaling (i.e. chronic stress) may be detrimental to brain functioning and plasticity [2] .
Role of CRF in mood disorders
CRF is expressed throughout the central nervous system, with high expression in the limbic regions, implicating its role in the pathophysiology of depression and anxiety. As mentioned above, CRF is the main neurohormone involved in the stress response, and its behavioural effects are associated with stimulation of CRF-R1 and CRF-R2 receptors in extra-hypothalamic regions [5, 6] . In particular, CRF release during stress activates neuronal projections in the limbic system, such as the basolateral nucleus of the amygdala, and has anxiogenic effects [7] . Moreover, excess CRF secretion can be detrimental to brain development and morphology, as it is shown to affect the hippocampus, a brain region involved in the glucocorticoid negative feedback circuit [4] . Specifically, hippocampal neurogenesis may be suppressed, affecting neuronal synapse formation and networks.
CRF is also released in the dorsal raphe nucleus (associated with serotonergic projections) and locus coeruleus (associated with noradrenaline projections), further supporting the role of CRF in depression [8] .
Evidence also shows increased cerebrospinal fluid concentrations of CRF in suicide victims, and higher numbers of CRF-producing paraventricular nucleus neurons in those with depression [9, 10] . In addition, hyperactivation of the CRF pathway leads to elevated hypothalamic CRF levels, potentially disrupting sleep, appetite, and libido [8] . Research of human CRF genetics reveals that CRF-related single nucleotide polymorphisms (SNP) may affect CRF hyperactivity and increase the vulnerability of developing depression [11] . In particular, individuals with major depression have SNP in the CRF-binding protein (CRF-BP) gene, which is involved in regulating CRF availability in the central nervous system.
In terms of potential therapies, clinical studies suggest that selective CRF receptor antagonists may serve as antidepressants [7] . However, centrally administering CRF receptor antagonists in the brain appears to be anxiolytic, but with low efficacy [10] . After a number of gene duplication events in chordates (and hence mammals and humans), a number of CRF paralogues were formed, including the urocortin peptides (urocortin-1, urocortin-2, and urocortin-3) [12] . Also, CRF orthologues were established such as the diuretic hormone in insects, urotensin-1 in fish and sauvagine in frogs [12] . Progenitors of CRF-like peptides then developed, including calcitonin, glucagon, secretin, and pituitary adenylyl cyclaseactivating peptide (PACAP) [13] . Not only do these CRF progenitor peptides share similar secondary structures, but their receptors also show structural homology (i.e. long N-terminus and seven transmembrane domains).
Another peptide that shares a similar amino acid sequence with CRF is the teneurin C-terminal associated peptide (TCAP) (Fig. 1) .
Found on the extracellular tip of teneurin transmembrane proteins, TCAP has about a 20% sequence similarity to CRF, and it is suggested that TCAP, CRF, and calcitonin families all share a common genomic origin [14] . Once cleaved from its proprotein, TCAP is 
Discovery of teneurins and TCAP
The first discovery of teneurins was by a group of researchers examining tenascinrelated genes in Drosophila [15] . They initially found Drosophila teneurin-accessory (ten-a), and teneurin-major (ten-m/Odz) genes; and later, four teneurin paralogues (ten-1-4) were discovered in vertebrates [16] . Teneurins are expressed in both neural and non-neural tissues, but are most prominent in the central nervous system and during morphogenesis.
For example, ten-1-3 are found in the CA2 region of the hippocampus, and ten-1-4 are all expressed in the dentate gyrus [17] . In addition, teneurins are involved in the development of visual, olfactory, and auditory systems [18, 19] .
Teneurins exhibit a unique architecture with several functional domains, and have 300-375 and 2400 amino acids on the intracellular and extracellular domains, respectively [16] . and is located on the presynaptic plasma membrane [22, 23] . The vertebrate LPHN was originally purified using α-latrotoxin (α-LTX) affinity chromatography, partially sequenced, cloned and over-expressed [24, 25] . Evidence indicates that LPHN is the receptor for the black widow spider toxin; α-LTX, and α-LTX binding stimulates exocytosis of neurotransmitters from synaptic vesicles [25] . LPHN has three known homologues (LPHN-1-3) , and LPHN- We previously established that TCAP activates a cAMP system [21, 34] , and in addition, stimulates a MEK-ERK1/2 signal cascade [35] to stimulate a number of cytosolic processes. For example, activation of the MEK-ERK1/2 pathway leads to increased cytoskeletal growth and microtubule dynamics in neuronal cells [35] . These studies also established an association of the TCAP receptor with the dystroglycans (Fig. 2) [35] [36] [37] . Thus, exogenous synthetic TCAP-1 could act through its association with LPHN causing downstream effects of the Gαq11 unit.
Effects of TCAP/teneurinlatrophilin interactions on mood disorder associated behaviours
Teneurin/TCAP
TCAP has been studied with emphasis on pathways related to anxiety and emotionality suggesting a role in mood disorders. The acoustic startle test is particularly useful at assessing the innate anxiety in naïve animals.
When treated with intracerebroventricular (ICV) TCAP-1, high-reactive rats had a reduced acoustic startle response, whereas low-reactive rats had an increased response, indicating that TCAP may have a normalizing effect on behaviour [34] . Moreover, in a subsequent study, TCAP-1 could block the CRF-mediated action on the acoustic startle test [38] . In addition, addiction behaviours can be increased during periods of CRF-induced anxiety. When synthetic TCAP-1 was administered ICV, rats with a 3 hour-period of cocaine access showed an attenuated CRF-mediated cocaine-seeking response [39] . In another study, rats injected intravenously (IV) with TCAP-1 were subjected to either a 3-hour (short access) or 6-hour (long access) period of cocaine exposure during the reinstatement period [40] . Interestingly, in short-access rats, the lower dose of TCAP (300 pmol) was effective at blocking the CRF-induced cocaine reinstatement. However, in long-access rats, only the higher dose of TCAP (3000 pmol) was effective in ablating cocaine addiction.
These findings suggest that TCAP-1 could be acting through its own receptor signaling system to mediate neuroplastic changes and [42, 43] . Additionally, teneurins are integral to the normal development of visual, auditory, and olfactory pathways [43, 44] . For example, teneurin-3 is required for binocular vision, as it regulates mapping of ipsilateral axons connecting the ventral retina to the dorsal lateral geniculate nucleus [43] .
Moreover, teneurin-1 is expressed prominently in the L5 and L6 regions of the neocortex [29] and in the piriform cortex, a region associated with processing of odour and pheromone signals [34] . Ultimately, teneurins are important for basic brain maturation and function, as they regulate synaptic plasticity and modulate sensory processes.
Conclusion
Taken together, these studies indicate that the teneurin/TCAP system is an essential component of sensory processing. Sensory regulation and integration is a key component of mood disorders. Because the length of teneurin and LPHN together can span the synaptic cleft [22] , this allows teneurins to interact with adjacent neurons thus increasing efficiency of the synapse. Thus, by regulating the efficacy of this synapse, modulation of the teneurin/TCAP-latrophilin pair has the potential to regulate a number of mood disorders.
